TWST

#1573
Twist Bioscience Corporation Common Stock
57.62 USD
+0.37%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
57.62
57.62
Jahresspanne
23.30
59.00
Tagesänderung
+0.37%
Monatliche Änderung
+32.25%
6 month change
+77.73%
Jahresänderung
+48.85%
Vorheriger Schlusskurs
57.41
Eröffnung
57.62
Bid
Ask
Tief
57.62
High
57.62
Volumen
108
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Nachrichten